cardiovascular tissues. However, key structural features of the native ECM need to be identified and incorporated (with adequate resolution and reliability) into a scaffold to promote cell function and limit detrimental effects. In addition, from the potential clinical application perspective, a high level of quality control of the scaffold product is required, which can only be achieved by a computer-controlled 3D printing technology.
The position of crosslinks within a matrix of photoactive biological polymers can be controlled with high resolution. Printers that use single-photon excitation coupled to a sequence of photomasks can achieve ≈30 µm resolution in x and y and ≈50 µm resolution in z. A more advanced technique, multiphoton-excited (MPE) photochemistry, can restrict excitation (and, consequently, the photochemical reaction) in 3 dimensions via a method that is analogous to multiphoton laser scanning microscopy. [9] [10] [11] [12] [13] [14] Notably, the resolution of the features (<1 μm) is determined by the MPE point spread function and can therefore approximate the feature size of components of the ECM. 15 The technique can also be combined with rapid prototyping and computer-aided design 16 to fabricate essentially any 3D structure that can be drawn.
For the experiments described in this report, we used our novel technique, MPE 3-dimensional (3D) printing, to generate a scaffold with a native-like cardiac ECM architecture from a solution of a photoactive gelatin polymer and then seeded the scaffold with cardiac cells (cardiomyocytes, endothelial cells [ECs] , and smooth muscle cells [SMCs] ) that had been differentiated from human cardiac-lineage-induced pluripotent stem cells (hciPSCs) 17 to generate an hciPSC-derived cardiac muscle patch (hCMP). The hCMP was subsequently characterized via a series of in vitro analyses and then tested in a murine model of ischemic myocardial injury.
Methods
A detailed description of the experimental procedures used in this investigation is provided in the Online Data Supplement.
Results

Fabrication of an ECM Scaffold Based on Templates Derived From Optical Image Stacks of Murine Myocardium
Our approach can be summarized in 2 steps: first, native, murine, adult myocardial tissue was examined to determine the size and distribution of various ECM features, which were incorporated into a 3D template; then, the template was scanned and used to map the positions of crosslinks in a solution of a photoactive polymer ( Figure 1A) . Importantly, our scanning technique, modulated raster scanning, maps the template directly to the scaffold by monitoring the brightness of each point in the image, and it is accurate to the resolutions of <1 μm. To our knowledge, this is the first time modulated raster scanning has ever been successfully used to control the fabrication of a tissue-engineered scaffold, and, consequently, our results are particularly relevant for applications that require the fibrillar and mesh-like structures present in cardiac tissue. 18 We chose to base our template on the distribution of fibronectin in murine myocardium ( Figure 1B and 1C) . Fibronectin is uniformly distributed around each cardiomyocyte, so it can be used to determine the dimensions of each individual cell Nonstandard Abbreviations and Acronyms 
Novelty and Significance
What Is Known?
• Cellular therapy for myocardial repair has shown some benefit in preclinical and clinical settings, but limited cell retention and associated lack of robust electromechanical coupling remain the major problems.
• Greater benefits may be achieved if the transplanted cardiac cells are provided with structural support such that synchronized contractile activity of the graft can be integrated to recipient heart. • One approach to generate a structural support is 3D printing, which has recently advanced to include the printing of biological materials such as cells and extracellular matrix proteins.
What New Information Does This Article Contribute?
• The article describes the implementation of multiphoton-excited 3-dimensional printing to generate a scaffold with native-like cardiac extracellular matrix architecture. The scaffold can effectively harbor stem cell-derived cardiac cell types and can be handled for effective transfer to the damaged heart. • The cell-seeded scaffold (termed human cardiac muscle patch) beats synchronously in a culture dish before transplant and with extended culture time beats with increased speed and calcium handling suggesting cardiomyocyte maturation. In vivo measurements of cardiac function and infarct size were significantly better in infarcted hearts treated with the human cardiac muscle patches than in hearts treated with cell-free scaffolds.
• The mechanisms for therapeutic improvement include improved cell engraftment, increased cellular proliferation, and vascular supply with decreased apoptosis.
We demonstrate multiphoton-excited 3D printing to generate a human cardiac muscle patch that could be effectively populated with cardiac cell types because it mimics the structural dimensions and protein composition of the native myocardium. In a mouse model of myocardial infarction, human cardiac muscle patch transplantation results in higher levels of cell engraftment, cell proliferation, and myocardial vascular density, which are accompanied by a significant reduction of infarct size and improvement of left ventricular function. This work pushes the technical limits of 3D printing for cardiac tissue equivalents such that cells and extracellular matrix proteins could be manufactured precisely as designed.
compartment to form a grid (here termed, adult simulate). The scaffold was generated from a solution of gelatin methacrylate, which can be crosslinked into complex structures with high efficiency, allows creation of complex structures with thickness of ≈100 μm (Online Movies I through III), and is biologically inert when both crosslinked and degraded, and the denatured collagen exposes cell binding sites (including Arg-Gly-Asp [RGD]), which should readily adhere to the seeded cells and support biochemical signaling via focal adhesions. 19 Analysis of the native myocardium suggested that cardiomyocytes reside in channels that are ≈15 μm by 100 μm which, when incorporated in the hCMP scaffold ( Figure 1D and 1E), yielded a robust structure with high reproducibility and exceptional fidelity in both coverage area (≥95%) and intensity variation (≥85%).
Integration of hciPSC-Derived Cardiac Cells in hCMPs
The hciPSCs were reprogrammed from human cardiac fibroblasts and differentiated into hciPSC-cardiomyocytes, hciPSCSMCs, and hciPSC-ECs; then, the differentiated cells were characterized via the expression of lineage-specific markers (Online Figure I) , and the hCMP was formed by seeding ≈50 000 cells (in a 2:1:1 ratio of hciPSC-cardiomyocytes, hciPSC-SMCs, and hciPSC-ECs, respectively) into the fabricated scaffold, where they quickly became assimilated and occupied most of the free space ( Figure 1D ). The hciPSC-cardiomyocytes began generating calcium transients ( Figure 2A ) and beat synchronously across the entire hCMP within 1 day of seeding (Online Movies IV and V). Over the next 7 days, the speeds of contraction and relaxation, the peak amplitude of the calcium transients ( Figure 2B communications between cells. Conduction velocity in hCMPs increased linearly with the increase of pacing cycle length, reaching 18.8±0.8 cm/s at 800 ms pacing cycle length ( Figure 2F ). Action potential durations, APD 50 and APD 80 , were ≈214±10. 4 and 270±12.7 ms at 800 ms pacing cycle length, separately, and also showed significant correlation with pacing rate ( Figure 2G ). Autofluorescence images obtained via 2-photon microscopy on day 7 ( Figure 2H ) indicated that the cells had aligned with the channels of the fabricated scaffold ( Figure 2I ) to form multinucleate cells with an aspect ratio (ie, cell length:width) of ≈5.5:1 ( Figure 2J ), which is close to the characteristic ratio observed in native cardiomyocytes (7:1). Analysis of hCMPs stained for the expression of the cardiomyocyte protein cTnI, α-smooth muscle actin, and the endothelial marker CD31 ( Figure 2K ) indicated that the original 2:1:1 ratio of hciPSC-cardiomyocytes, hciPSCSMCs, and hciPSC-ECs was largely retained (Figure 2 L) , with cardiomyocytes comprising ≈45% of the remaining cells. The 7-day survival rate of hciPSC-cardiomyocytes in the hCMP was similar to that observed when cells were maintained on Matrigelcoated plates and significantly greater than the rate achieved by culturing the cells with bovine pericardium or polyethylene glycol ( Figure 2M ).
In Vivo Evaluations of hCMP Transplantation in a Murine Model of Myocardial Infarction
In vivo assessments of the hCMPs were performed in a murine model of myocardial infarction (MI). MI was surgically induced as described previously, 20 then animals in the MI+hCMP group were treated with 2 hCMPs, animals in the MI+Scaffold group were treated with 2 patches of scaffold material without cells, and animals in the MI group received neither the hCMP nor the cell-free scaffold. The hCMPs and scaffolds were positioned over the site of infarction ( Figure  3A ) and held in place by covering them with a piece of decellularized bovine pericardium that was sutured to the heart to avoid movement of hCMPs off the heart. The decellularized bovine pericardium above the hCMP has beneficial effect of preventing the adhesion between the heart/hCMP and the chest. The Sham group underwent all the surgical procedures for MI induction except the ligation step and recovered without either experimental treatment. Quantitative polymerase chain reaction measurements for expression of the human Y chromosome indicated that 24.5±2.6% of the transplanted cells remained engrafted in the hearts of MI+hCMP animals for at least 1 week after transplantation ( Figure 3B) . By week 4, the engraftment rate had declined to 11.2±2.3%, which is still much higher than the rate reported in previous studies of cell-based myocardial therapy. 21, 22 To assess the engraftment rate by counting the grafted human cells as evidenced by human-specific nuclear antigen positivity, we also used histological assessment of consecutive sections of the heart that spans the entire area covered by the engrafted patch and counting the grafted human cells as evidenced by humanspecific nuclear antigen positivity. 17, 23 The engraftment rate of the 7 hearts studied using the histology method is 13.6±2.2%, which is in agreement with the quantitative polymerase chain reaction (11.2±2.3%). The ratio of the hciPSC-tri-lineage cardiac cells at weeks 1 and 4 was also examined. The engrafted hciPSC-cardiomyocytes were identified by the expression of both green fluorescent protein and cTnI, engrafted hiPSC-ECs were identified by the expression of human-specific CD31, and engrafted hiPSC-SMCs were identified by the expression of both green fluorescent protein and α-smooth muscle actin. At week 1 post-transplantation, the ratio of hciPSC-cardiomyocytes, hciPSC-SMCs, and hciPSC-ECs was 1.42:0.93:1; at week 4, the ratio was 0.67:0.86:1 for hciPSC-cardiomyocytes, hciPSC-SMCs, and hciPSC-ECs, respectively. Hematoxylin and eosin staining ( Figure 3C ) and immunofluorescence analysis of human-specific nuclear antigen, green fluorescent protein, cTnI, α-smooth muscle actin, and human-specific CD31 expression ( Figure 3C and 3D) showed evidence of all 3 transplanted cell lineages in the treated region.
Cardiac function was evaluated on day 28 after injury via echocardiographic assessments ( Figure 4A ) of left ventricular ejection fraction and fractional shortening; both parameters were significantly greater for animals in the MI+hCMP group than in MI+Scaffold or MI animals ( Figure 4B and 4C) , although measurements in the MI+Scaffold and MI groups were similar. Infarcts were also significantly smaller, although the thickness of the infarcted region of the myocardial wall was significantly greater in MI+hCMP hearts than in MI or MI+Scaffold hearts ( Figure 4D through 4F) , and analyses of TUNEL (terminal deoxynucleotidyl transferase dUTP nickend labeling)-stained sections (Online Figure IIIA and IIIB) and sections stained for the presence of CD31 and α-smooth muscle actin (Online Figure IIIC through IIIE) indicated that apoptotic cells were significantly less common, whereas vascular structures (including arterioles) were significantly more common, at the border of the infarcted region in hCMP-treated animals than in the corresponding regions of hearts from animals in the MI+Scaffold or MI groups. hCMP treatment was also associated with significant increases in the number of cells that expressed the proliferation marker Ki67 (Online Figure  IV) . Thus, the transplanted hCMPs seemed to improve recovery from myocardial injury by, at least in part, reducing apoptosis, promoting angiogenesis, and increasing cell proliferation.
Discussion
The fate specification of progenitor cells in the developing heart is critically dependent on the spatial and temporal factors of the ECM where the progenitor cells reside. In human pluripotent stem cell differentiation to ECs, the rate and quality of derived ECs are critically influenced by the temporal factors in 3D ECM. 24 The myocardial ECM provides substrates for cell adhesion, sequesters soluble factors, and serves as a conduit for mechanical signaling. Our recent efforts to characterize the ECM of the developing heart have provided us with an extensive body of knowledge on the nanoscale distribution of the ECM, 25 and by combining this knowledge with MPE 3D printing, we were able to generate a scaffold that is structurally native like. 16 The technique couples MPE with modulated raster scanning to induce crosslinks in a solution of a photoactive gelatin polymer, thereby creating an ECM scaffold with exceptionally high resolution. Notably, construction was guided by a template composed of features that had been identified in the ECM of a native adult murine heart, which suggests that the technique may be able to replicate the unique architecture of the myocardial ECM in each individual. Furthermore, when hCMPs were generated by seeding the scaffolds with hciPSC-derived cardiac cells and transplanted into infarcted mouse hearts, the treatment was associated with significant improvements in cardiac function, infarct size, apoptosis, vascular density, and cell proliferation. Thus, the hCMPs produced for this report may represent an important step toward the clinical use of 3D printing technology. 1 million cells total) . A, The representative image showed 2 transplanted hCMPs on the mouse heart. B, The engraftment rate was determined in animals from the MI+hCMP group at wk 1 and 4 after injury via quantitative polymerase chain reaction measurements of the human Y chromosome (n=4 hearts per time point). C, The representative Hematoxylin and eosin (HE) staining image and human-specific nuclear antigen (HNA) immunostaining image showed engrafted hCMP on the epicardial surface of the heart at wk 4 after transplantation. D, Sections taken from the region of patch in MI+hCMP animals at wk 4 were immunofluorescently stained for the presence of HNA, cardiac troponin I (cTnI), green fluorescent protein (GFP), α-smooth muscle actin (α-SMA), and the human isoform of the endothelial marker CD31 (hCD31); nuclei were counterstained with DAPI (scale bar=50 μm). (i and ii) Engrafted human cardiaclineage-induced pluripotent stem cells (hciPSC)-cardiomyocytes (CMs) were identified by the expression of both HNA and cTnI (i) or both GFP and cTnI (ii); (iii) engrafted hiPSC-smooth muscle cells (SMCs) were identified by the expression of both GFP and α-SMA; and (iv) engrafted hiPSC-endothelial cells (ECs) were identified by the expression of hCD31. BP indicates bovine pericardium. 
